Thomas Jonassen

Thomas Jonassen

Chief Tech/Sci/R&D Officer at SYNACT PHARMA AB

Net worth: 5 M $ as of 31/05/2026

Health Technology
Consumer Services

Profile

Thomas Jonassen is the founder.
Dr. Jonassen was the founder of Action Pharma A, founded in 2000, holding the title of Chief Scientific Officer.
Dr. Jonassen is also the founder of TXP Pharma GmbH,ResoTher Pharma AS.
Dr. Jonassen is currently an Associate Professor at the University of Copenhagen and the Chief Scientific Officer at SynAct Pharma AB starting in 2024.
Dr. Jonassen holds a doctorate from the University of Copenhagen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/12/2025 2,545,320 ( 4.77% ) 5 M $ 31/05/2026

Thomas Jonassen active positions

CompaniesPositionStart
SYNACT PHARMA AB Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Founder -

Former positions of Thomas Jonassen

CompaniesPositionEnd
TXP Pharma GmbH
Founder -
Founder -
See the detail of Thomas Jonassen's experience

Training of Thomas Jonassen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

26

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Health Technology

Health Technology

TXP Pharma GmbH

Health Technology

  1. Stock Market
  2. Insiders
  3. Thomas Jonassen
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!